Application of Novel Drugs for Corneal Cell Regeneration
Joint Authors
Liu, Yu-Chi
Mohamed-Noriega, Karim
Han, Sang Beom
Mehta, Jodhbir S.
Source
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-9, 9 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-05-02
Country of Publication
Egypt
No. of Pages
9
Main Subjects
Abstract EN
Corneal transplantation has been the only treatment method for corneal blindness, which is the major cause of reversible blindness.
However, despite the advancement of surgical techniques for corneal transplantation, demand for the surgery can never be met due to a global shortage of donor cornea.
The development of bioengineering and pharmaceutical technology provided us with novel drugs and biomaterials that can be used for innovative treatment methods for corneal diseases.
In this review, the authors will discuss the efficacy and safety of pharmacologic therapies, such as Rho-kinase (ROCK) inhibitors, blood-derived products, growth factors, and regenerating agent on corneal cell regeneration.
The promising results of these agents suggest that these can be viable options for corneal reconstruction and visual rehabilitation.
American Psychological Association (APA)
Han, Sang Beom& Liu, Yu-Chi& Mohamed-Noriega, Karim& Mehta, Jodhbir S.. 2018. Application of Novel Drugs for Corneal Cell Regeneration. Journal of Ophthalmology،Vol. 2018, no. 2018, pp.1-9.
https://search.emarefa.net/detail/BIM-1196143
Modern Language Association (MLA)
Han, Sang Beom…[et al.]. Application of Novel Drugs for Corneal Cell Regeneration. Journal of Ophthalmology No. 2018 (2018), pp.1-9.
https://search.emarefa.net/detail/BIM-1196143
American Medical Association (AMA)
Han, Sang Beom& Liu, Yu-Chi& Mohamed-Noriega, Karim& Mehta, Jodhbir S.. Application of Novel Drugs for Corneal Cell Regeneration. Journal of Ophthalmology. 2018. Vol. 2018, no. 2018, pp.1-9.
https://search.emarefa.net/detail/BIM-1196143
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1196143